Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 10.17%
March 31, 2026 9.01%
December 31, 2025 4.74%
September 30, 2025 7.35%
June 30, 2025 5.86%
March 31, 2025 8.22%
December 31, 2024 2.50%
September 30, 2024 2.84%
June 30, 2024 4.47%
March 31, 2024 6.52%
December 31, 2023 1.46%
September 30, 2023 3.05%
June 30, 2023 15.69%
March 31, 2023 13.62%
December 31, 2022 19.31%
September 30, 2022 19.45%
June 30, 2022 21.48%
March 31, 2022 27.05%
December 31, 2021 2.61%
September 30, 2021 16.07%
June 30, 2021 17.91%
March 31, 2021 15.86%
December 31, 2020 13.87%
September 30, 2020 15.23%
June 30, 2020 9.60%
Date Value
March 31, 2020 12.77%
December 31, 2019 10.56%
September 30, 2019 11.84%
June 30, 2019 13.42%
March 31, 2019 12.10%
December 31, 2018 16.51%
September 30, 2018 11.99%
June 30, 2018 11.26%
March 31, 2018 10.33%
December 31, 2017 16.04%
September 30, 2017 9.56%
June 30, 2017 8.54%
March 31, 2017 11.05%
December 31, 2016 9.52%
September 30, 2016 11.45%
June 30, 2016 12.30%
March 31, 2016 11.39%
December 31, 2015 8.54%
September 30, 2015 13.63%
June 30, 2015 12.08%
March 31, 2015 7.56%
December 31, 2014 6.19%
September 30, 2014 8.31%
June 30, 2014 7.09%
March 31, 2014 7.19%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Evotec SE -32.51%
Gerresheimer AG -22.64%
Lifecore Biomedical, Inc. -18.02%
Mesa Laboratories, Inc. 4.71%
Repligen Corp. 2.45%